The Dixie Group (DXYN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for May 7, 2025, to elect six directors, hold a say-on-pay vote, and ratify the external auditor for 2025.
Shareholders of record as of March 10, 2025, are eligible to vote; proxy materials are available online.
Board recommends voting FOR all proposals, including director nominees, executive compensation, and auditor ratification.
Voting matters and shareholder proposals
Proposals include election of six directors, advisory vote on executive compensation, and ratification of Forvis Mazars, LLP as independent auditor.
Shareholders may submit proposals for the 2026 meeting by November 5, 2025.
Each Common Stock share has one vote; each Class B Common Stock share has 20 votes.
Board of directors and corporate governance
Board consists of six nominees with diverse backgrounds in finance, operations, academia, and environmental compliance.
Four directors are independent per SEC and NASDAQ standards; independent directors meet in executive session quarterly.
Board committees include Executive, Audit, and Compensation/Nominations and Corporate Governance Committees.
Board met five times in 2024; all directors attended at least 75% of meetings.
Succession planning for executive roles is reviewed periodically.
Latest events from The Dixie Group
- Proxy seeks approval for directors, executive pay, and auditor, with strong governance focus.DXYN
Proxy filing26 Mar 2026 - Improved margins and reduced losses amid industry headwinds and tariff challenges.DXYN
Q4 202526 Mar 2026 - Profitability returned in Q2 2024 as cost savings and efficiencies offset weak sales.DXYN
Q2 20242 Feb 2026 - Q3 sales and margins declined, losses widened, and cost cuts target recovery as housing rebounds.DXYN
Q3 202417 Jan 2026 - Net loss widened to $13M in 2024 as sales fell and cost actions intensified amid industry headwinds.DXYN
Q4 202424 Nov 2025 - Q2 2025 saw higher net income and margins despite lower sales, with ongoing liquidity risks.DXYN
Q2 202523 Nov 2025 - Gross margin rose to 26.8% as net loss narrowed, but market and liquidity risks persist.DXYN
Q1 202521 Nov 2025 - Q3 2025 sales declined, but cost controls and a profit plan aim to drive future recovery.DXYN
Q3 202517 Nov 2025